Matthew A. Lakins

636 total citations · 1 hit paper
9 papers, 494 citations indexed

About

Matthew A. Lakins is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Matthew A. Lakins has authored 9 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Matthew A. Lakins's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Matthew A. Lakins is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Matthew A. Lakins collaborates with scholars based in United Kingdom, Spain and Japan. Matthew A. Lakins's co-authors include Ehsan Ghorani, Jacqueline D. Shields, Hafsa Munir, Carla P. Martins, Sarah Batey, Emma Goodman, Jose Muñoz-Olaya, Robert Hughes, Neil Brewis and Alexander Koers and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Matthew A. Lakins

9 papers receiving 488 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells

2018 437 citations Matthew A. Lakins, Ehsan Ghorani et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew A. Lakins United Kingdom	4	369	264	153	87	53	9	494
Christopher D. Zahm United States	13	305 0.8×	237 0.9×	139 0.9×	63 0.7×	90 1.7×	20	474
Amy K. Erbe United States	15	329 0.9×	314 1.2×	100 0.7×	60 0.7×	42 0.8×	55	525
David J. Bajor United States	6	418 1.1×	140 0.5×	131 0.9×	106 1.2×	59 1.1×	15	491
Priska Auf der Maur Switzerland	5	240 0.7×	174 0.7×	160 1.0×	96 1.1×	54 1.0×	6	412
Huda I. Atiya United States	8	258 0.7×	202 0.8×	175 1.1×	114 1.3×	61 1.2×	11	491
Alexandro Landshammer Germany	6	322 0.9×	229 0.9×	122 0.8×	44 0.5×	81 1.5×	8	476
Shamik Mitra Sweden	6	331 0.9×	209 0.8×	201 1.3×	101 1.2×	117 2.2×	12	476
Ryota Kondou Japan	9	229 0.6×	186 0.7×	105 0.7×	38 0.4×	33 0.6×	18	358
Shiyao Du China	7	221 0.6×	218 0.8×	131 0.9×	48 0.6×	38 0.7×	11	385
Annelisa M. Cornel Netherlands	9	245 0.7×	229 0.9×	164 1.1×	52 0.6×	26 0.5×	16	439

Countries citing papers authored by Matthew A. Lakins

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Lakins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Lakins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Lakins more than expected).

Fields of papers citing papers by Matthew A. Lakins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Lakins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Lakins. The network helps show where Matthew A. Lakins may publish in the future.

Co-authorship network of co-authors of Matthew A. Lakins

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Lakins. A scholar is included among the top collaborators of Matthew A. Lakins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Lakins. Matthew A. Lakins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Imianowski, Charlotte J., Paula Kuo, Sarah K. Whiteside, et al.. (2024). IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy. Cancer Research Communications. 4(8). 2045–2057. 3 indexed citations

Lakins, Matthew A., Emma McConnell, Cristian Grădinaru, et al.. (2021). 573 FS120, an OX40/CD137 tetravalent bispecific dual agonist antibody, synergistically increases the antitumor activity of anti-PD-1 in preclinical studies. SHILAP Revista de lepidopterología. A602–A602. 1 indexed citations

Garralda, Elena, Ignacio Melero, Guillermo de Velasco, et al.. (2021). 165TiP A first-in-human phase I study of FS222, a CD137/PD-L1 tetravalent bispecific antibody, in patients with advanced malignancies. Annals of Oncology. 32. S1454–S1454. 1 indexed citations

Lakins, Matthew A., Alexander Koers, Jose Muñoz-Olaya, et al.. (2020). FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models. Clinical Cancer Research. 26(15). 4154–4167. 44 indexed citations

Lakins, Matthew A., Alexander Koers, Robert Hughes, et al.. (2020). Abstract 4547: Clustering CD137 via cell-expressed PD-L1 crosslinking avoided Fc-mediated agonism and resulted in safe and potent conditional lymphocyte activation. Cancer Research. 80(16_Supplement). 4547–4547. 1 indexed citations

Lakins, Matthew A., Alexander Koers, D. H. Jones, et al.. (2019). Abstract 1540: FS222 mAb², a bispecific conditional agonist antibody targeting CD137 and PD-L1, induces potent lymphocyte activation and has a favorable safety profile. Immunology. 1540–1540. 1 indexed citations

Lakins, Matthew A., Alexander Koers, Daniel B. Jones, et al.. (2019). Abstract 1540: FS222 mAb2, a bispecific conditional agonist antibody targeting CD137 and PD-L1, induces potent lymphocyte activation and has a favorable safety profile. Cancer Research. 79(13_Supplement). 1540–1540. 1 indexed citations

Lakins, Matthew A., Ehsan Ghorani, Hafsa Munir, Carla P. Martins, & Jacqueline D. Shields. (2018). Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells. Nature Communications. 9(1). 948–948. 437 indexed citations breakdown →

Lakins, Matthew A., Joanne Marrison, Peter O’Toole, & Marjan W. van der Woude. (2009). Exploiting advances in imaging technology to study biofilms by applying multiphoton laser scanning microscopy as an imaging and manipulation tool. Journal of Microscopy. 235(2). 128–137. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact